Format

Send to

Choose Destination
Transl Gastroenterol Hepatol. 2019 May 15;4:31. doi: 10.21037/tgh.2019.04.08. eCollection 2019.

To BE or not to BE: non-invasive screening for Barrett's esophagus, dysplasia and adenocarcinoma.

Author information

1
QIMR Berghofer Medical Research Institute, Brisbane, Australia.
2
Advanced Digestive Institute, University Medical Center (UMC), New Orleans, Louisiana, USA.
3
The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, Australia.

Conflict of interest statement

Conflicts of Interest: AK Shah and MM Hill are inventors on patent applications for serum glycoprotein biomarkers for esophageal adenocarcinoma. The other authors have no conflicts of interest to declare.

Supplemental Content

Full text links

Icon for AME Publishing Company Icon for PubMed Central
Loading ...
Support Center